Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.

By Dinna Cruz, M. Antonelli, R. Fumagalli, F. Foltran, N. Brienza, A. Donati, V. Malcangi, F. Petrini, G. Volta, F. Bobbio Pallavicini and 3 more. Journal of the American Medical Association (JAMA), 2009

751 citations recorded by the source corpus.

Subfields: Epidemiology, Immunology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/30a6e9d94da7b87d525e773219ae4879a87ead7d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. A. Rhodes
2. Laura Evans
3. M. Cecconi
4. Mitchell M. Levy

Citations in the corpus

• Sepsis and septic shock. (2018, result): “132 Endotoxin removal via polymyxin B haemoperfusion is an novel therapeutic approach that is still under investigation, with inconsistent results: some initial trials showed an improvement in outcome, 133 whereas a more recent multicentre RCT showed a non-significant increase in mortality.”